Company Snapshot: HOLX  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Hologic to Present at the Raymond James 30th Annual Institutional Investors Conference
 

BEDFORD, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX) today announced that Glenn Muir, Chief Financial Officer, will be presenting at the Raymond James 30th Annual Institutional Investors Conference being held March 9, 2009 at the JW Marriott Grande Lakes hotel in Orlando, FL.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Monday, March 9, 2009, at 3:25 p.m. (Eastern) on the investor section of the company's website at www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

    Contact:
    Deborah Gordon                             Frances Doria
    Vice President, Investor Relations         Director, Investor Relations
    Hologic, Inc.                              Hologic, Inc.
    (781) 999-7716                             (781) 999-7377


SOURCE Hologic, Inc.